Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 6.7B | 6.2B | 5.4B | 7.6B |
Cost of revenue | 2.4B | 2.3B | 2.4B | 2.7B |
Gross profit | 4.3B | 3.9B | 3.0B | 4.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 1.9B | 2.2B | 907M | 2.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 1.1B | 1.8B | -725M | 1.8B |
Other income expense | 550M | -503M | -588M | 788M |
Pretax income | 1.4B | -57M | 1.0B | 1.6B |
Tax provision | -256M | -521M | 171M | 5M |
Net income | 1.6B | 464M | 873M | 1.6B |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 4.1B | 2.9B | 1.8B | 4.7B |
Net income from continuing op. | 1.6B | 464M | 873M | 1.6B |
Minority interests | 389M | 369M | 330M | 261M |
Preferred stock dividends | — | — | — | — |